NATALIA VIDEVA: Open Payments
NPI 1962906586 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 13 payments from 5 companies in 2025. Trend: 2023 $1,105 · 2024 $600 · 2025 $384
Food & beverage: $341Education: $43
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $165 |
| Janssen Pharmaceuticals, Inc | 4 | $103 |
| Mannkind Corporation | 3 | $81 |
| Dexcom, Inc. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: INVEGA SUSTENNA, AFREZZA, MOUNJARO, Dexcom G6 Transmitter, JARDIANCE.
Industry payments across NV — which companies pay providers there.
